- Home
- JKHY vs SNN Comparison
JKHY vs SNN Comparison
Compare JKHY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JKHY | SNN |
|---|---|---|
| Founded | 1976 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 14.0B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | JKHY | SNN |
|---|---|---|
| Price | $181.97 | $33.44 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 9 | 4 |
| Target Price | ★ $176.22 | $32.83 |
| AVG Volume (30 Days) | ★ 823.8K | 476.9K |
| Earning Date | 11-04-2025 | 03-02-2026 |
| Dividend Yield | 1.28% | ★ 2.19% |
| EPS Growth | 20.28 | ★ 59.91 |
| EPS | ★ 6.58 | 0.56 |
| Revenue | $2,419,044,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $6.98 | $7.78 |
| Revenue Next Year | $6.45 | $5.13 |
| P/E Ratio | ★ $27.62 | $29.10 |
| Revenue Growth | ★ 7.75 | 5.35 |
| 52 Week Low | $144.12 | $23.69 |
| 52 Week High | $196.00 | $38.79 |
Technical Indicators
Market Signals| Indicator | JKHY | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 79.13 | 48.01 |
| Support Level | $171.86 | $32.68 |
| Resistance Level | $175.90 | $33.56 |
| Average True Range (ATR) | 3.10 | 0.41 |
| MACD | 0.90 | 0.14 |
| Stochastic Oscillator | 99.21 | 78.51 |
Price Performance
Historical ComparisonAbout JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.